Rule 6, Drugs (Prices Control) Order, 2013: Ceiling price of a scheduled formulation in case of no reduction in price due to absence of competition
Drugs (Prices Control) Order, 2013 - Rule 6
Text of rule 6
Ceiling price of a scheduled formulation in case of no reduction in price due to absence of competition
6. Ceiling price of a scheduled formulation in case of no
reduction in price due to absence of competition.– (1) where
the average price to retailer of a scheduled formulation, arrived at as
per the formula specified in sub-paragraph (1) of paragraph 4, has
the effect of,-
(a) no reduction in average price to retailer with respect to the
prices to retailer of the schedule formulation; and
consider necessary and such manufacturer shall furnish the required
information within such time the Government may fix.
4. Calculation of ceiling price of a scheduled formulation.-— (1)
The ceiling price of a scheduled formulation of specified strengths
and dosages as specified under the first schedule shall be calculated
as under:
Step1. First the Average Price to Retailer of the scheduled
formulation i.e. P(s) shall be calculated as below:
Average Price to Retailer, P(s) = (Sum of prices to retailer of all
the brands and generic versions of the medicine having market
share more than or equal to one percent of the total market turnover
on the basis of moving annual turnover of that medicine) / (Total
number of such brands and generic versions of the medicine having
market share more than or equal to one percent of total market
turnover on the basis of moving annual turnover for that medicine. )
Step2. Thereafter, the ceiling price of the scheduled formulation i.e.
P(c) shall be calculated as below:
P(c) = P(s).(1+M/100), where
P(s) = Average Price to Retailer for the same strength and dosage of
the medicine as calculated in step1 above.
M = % Margin to retailer and its value =16
(2) The ceiling price calculated as per sub-paragraph (1) and notified
by the Government shall be applicable to scheduled imported
formulations also.
5. Calculation of retail price of a new drug for existing
manufacturers of scheduled formulations.— (1) The retail price
of the new drug available in domestic market shall be calculated as
provided in sub-paragraph (1) of paragraph 4.
(2) (i) the price to retailer of a new drug, not available in domestic
market, shall be fixed by the Government on the principles of
“Pharmacoeconomics” of the new drug, on the recommendation of a
Standing Committee of Experts formed under paragraph 15.
(ii) the retail price of such new drug shall be fixed by adding sixteen
percent margin to retailer on the price to retailer as fixed in item (i):
6. Ceiling price of a scheduled formulation in case of no
reduction in price due to absence of competition.— (1) where
the average price to retailer of a scheduled formulation, arrived at as
per the formula specified in sub-paragraph (1) of paragraph 4, has
the effect of,-
(a) no reduction in average price to retailer with respect to the
prices to retailer of the schedule formulation; and
(b) there are less than five manufacturers for that formulation
having one percent or more market share, the ceiling price shall be
calculated as under:-
(i) in the event of other strengths or dosage forms of the same
scheduled formulation is available in the list of scheduled
formulation, the average price to retailer shall be calculated as
under:
Step1: First the Average Price to Retailer of such scheduled
formulation i.e. P(s) shall be calculated as under:
P(s) = Pm{1-(Pi1+Pi2+…)/(N*100)} Where,
Pm = Price to Retailer of highest priced scheduled formulation under
consideration.
Pi = % reduction in Average Price to Retailer of other strengths and
dosage forms (calculated as in step1 of sub-paragraph (1) of
paragraph 4) in the list of schedule formulations w.r.t the highest
priced formulation taken for calculating the average price to retailer
of such strengths and dosage forms.
N = Number of such other strengths or dosage forms or both in the
list of schedule formulations
Step2. Thereafter, the ceiling price of the scheduled formulation i.e.
P(c) shall be calculated as under:
P(c) = P(s).(1+M/100), where
P(s) = Average Price to Retailer of the scheduled formulation as
calculated in step1 hereinabove and
M = % Margin to retailer and its value=16
(ii) in the event of other strengths or dosage forms of the scheduled
formulation is not available in the schedule but there are other
scheduled formulations in same sub-therapeutic category as that of
the scheduled formulation, then the Ceiling Price shall be calculated
as under:
Step1: First the Average Price to Retailer of such scheduled
formulation i.e. P(s) shall be calculated as under:
P(s) = Pm{1-(Pi1+Pi2+…)/(N*100)}, Where,
Pm = Price of highest priced formulation taken for calculating the
average price to retailer of the formulation under consideration..
Pi = % reduction in Average Price to Retailer of other schedule
formulations (calculated as in step1 of sub-paragraph (1) of
paragraph 4) in same sub-therapeutic category as that of the
scheduled formulation under consideration w.r.t the highest priced
formulation taken for calculating the average price to retailer.
N = Number of such other schedule formulations in same sub-
therapeutic category as that of the scheduled formulation under
consideration.
(b) there are less than five manufacturers for that formulation
having one percent or more market share, the ceiling price shall be
calculated as under:-
(i) in the event of other strengths or dosage forms of the same
scheduled formulation is available in the list of scheduled
formulation, the average price to retailer shall be calculated as
under:
Stepi1: First the Average Price to Retailer of such scheduled
formulation i.e. P(s) shall be calculated as under:
P(s) = Pm{1-(Pi1+Pi2+...)/(N*100)} Where,
Pm = Price to Retailer of highest priced scheduled formulation under
consideration.
Pi = % reduction in Average Price to Retailer of other strengths and
dosage forms (calculated as in step1 of sub-paragraph (1) of
paragraph 4) in the list of schedule formulations w.r.t the highest
priced formulation taken for calculating the average price to retailer
of such strengths and dosage forms.
N = Number of such other strengths or dosage forms or both in the
list of schedule formulations
Step2. Thereafter, the ceiling price of the scheduled formulation i.e.
P(c) shall be calculated as under:
P(c) = P(s).(1+M/100), where
P(s) = Average Price to Retailer of the scheduled formulation as
calculated in step1 hereinabove and
M = % Margin to retailer and its value=16
(ii) in the event of other strengths or dosage forms of the scheduled
formulation is not available in the schedule but there are other
scheduled formulations in same sub-therapeutic category as that of
the scheduled formulation, then the Ceiling Price shall be calculated
as under:
Stepi1: First the Average Price to Retailer of such scheduled
formulation i.e. P(s) shall be calculated as under:
P(s) = Pm{1-(Pi1+Pi2+...)/(N*100)}, Where,
Pm = Price of highest priced formulation taken for calculating the
average price to retailer of the formulation under consideration..
Pi = % reduction in Average Price to Retailer of other schedule
formulations (calculated as in step1l of sub-paragraph (1) of
paragraph 4) in same sub-therapeutic category as that of the
scheduled formulation under consideration w.r.t the highest priced
formulation taken for calculating the average price to retailer.
N = Number of such other schedule formulations in same sub-
therapeutic category as that of the scheduled formulation under
consideration.
Step2. Thereafter, the ceiling price of the scheduled formulation i.e.
P(c) shall be calculated as under:
P(c) = P(s)*(1+M/100), where
P(s) = Average Price to Retailer of the scheduled formulation as
calculated in step1 above and
M = % Margin to retailer and its value=16
Explanation.- where the scheduled formulation under consideration
is coming under more than one sub-therapeutic category, the
Average Price to Retailer of the scheduled formulation shall be
calculated after taking into consideration the percentage reduction in
Average Price to Retailer of other schedule formulations under all
such sub-therapeutic categories and the lowest average price to
retailer shall be taken for calculating the ceiling price of the
scheduled formulation under consideration;
(iii) in case the other strengths or dosage forms of the scheduled
formulation are not available in the schedule and there is no sub
therapeutic category of the scheduled under consideration, the
ceiling price shall be calculated as under:
Step1: First the Average Price to Retailer of such scheduled
formulation i.e. P(s) shall be calculated as under:
P(s) = Pm{1-(Pi1+Pi2+…)/(N*100)} Where,
Pm = Price of highest priced formulation taken for calculating the
average price to retailer of the formulation under consideration.
Pi = % reduction in Average Price to Retailer of other schedule
formulations (calculated as in step1 sub-paragraph (1) of paragraph
4) in same therapeutic category as that of the scheduled formulation
under consideration w.r.t the highest priced formulation taken for
calculating the average price to retailer.
N = Number of such other schedule formulations in same
therapeutic category as that of the scheduled formulation under
consideration.
Step2. Thereafter, the ceiling price of the scheduled formulation i.e.
P(c) shall be calculated as under:
P(c) = P(s).(1+M/100), where
P(s) = Average Price to Retailer of the scheduled formulation as
calculated in step1 above and
M = % Margin to retailer and its value=16
Explanation.- where the scheduled formulation under consideration
is coming under more than one therapeutic category, the Average
Price to Retailer of the scheduled formulation shall be calculated
after taking into consideration the percentage reduction in Average
Price to Retailer of other schedule formulations under all such
therapeutic categories and the lowest average price to retailer shall
Step2. Thereafter, the ceiling price of the scheduled formulation i.e.
P(c) shall be calculated as under:
P(c) = P(s)*(1+M/100), where
P(s) = Average Price to Retailer of the scheduled formulation as
calculated in step1 above and
M = % Margin to retailer and its value=16
Explanation.- where the scheduled formulation under consideration
is coming under more than one sub-therapeutic category, the
Average Price to Retailer of the scheduled formulation shall be
calculated after taking into consideration the percentage reduction in
Average Price to Retailer of other schedule formulations under all
such sub-therapeutic categories and the lowest average price to
retailer shall be taken for calculating the ceiling price of the
scheduled formulation under consideration;
(iii) in case the other strengths or dosage forms of the scheduled
formulation are not available in the schedule and there is no sub
therapeutic category of the scheduled under consideration, the
ceiling price shall be calculated as under:
Stepi: First the Average Price to Retailer of such scheduled
formulation i.e. P(s) shall be calculated as under:
P(s) = Pm{1-(Pi1+Pi2+...)/(N*100)} Where,
Pm = Price of highest priced formulation taken for calculating the
average price to retailer of the formulation under consideration.
Pi = % reduction in Average Price to Retailer of other schedule
formulations (calculated as in step1 sub-paragraph (1) of paragraph
4) in same therapeutic category as that of the scheduled formulation
under consideration w.r.t the highest priced formulation taken for
calculating the average price to retailer.
N = Number of such other schedule formulations in same
therapeutic category as that of the scheduled formulation under
consideration.
Step2. Thereafter, the ceiling price of the scheduled formulation i.e.
P(c) shall be calculated as under:
P(c) = P(s).(1+M/100), where
P(s) = Average Price to Retailer of the scheduled formulation as
calculated in step1 above and
M = % Margin to retailer and its value=16
Explanation.- where the scheduled formulation under consideration
is coming under more than one therapeutic category, the Average
Price to Retailer of the scheduled formulation shall be calculated
after taking into consideration the percentage reduction in Average
Price to Retailer of other schedule formulations under all such
therapeutic categories and the lowest average price to retailer shall
be taken for calculating the ceiling price of the scheduled formulation
under consideration.
(2) Notwithstanding anything contained in this paragraph, where the
price has been fixed and notified by the Government under the
Drugs (Prices Control) Order, 1995 the provisions of sub-paragraph
(1) shall not apply.
Previous and next
Questions people ask
Is rule 6 of Drugs (Prices Control) Order, 2013 still in force?
No repeal of Drugs (Prices Control) Order, 2013 is recorded.